You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

Profile for World Intellectual Property Organization (WIPO) Patent: 03105856


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 03105856

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,168,620 Aug 24, 2026 Mylan Speciality Lp DYMISTA azelastine hydrochloride; fluticasone propionate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Scope, Claims, and Patent Landscape for WIPO Patent WO03105856

Last updated: August 8, 2025


Introduction

Patent application WO03105856, filed under the auspices of the World Intellectual Property Organization (WIPO), signifies a strategic step in pharmaceutical innovation. While WIPO patents typically serve as international placeholder applications, their scope and claims offer vital insights into the inventive landscape, potential commercial applications, and competitive positioning within the targeted therapeutic domain.

This analysis meticulously dissects WO03105856's scope, claims, and the broader patent landscape, elucidating implications for stakeholders including research entities, pharmaceutical companies, and intellectual property strategists.


Scope and Objectives of WO03105856

The patent application WO03105856 primarily aims to protect specific chemical entities, their therapeutic uses, formulations, and manufacturing processes. It covers novel compounds believed to possess pharmacologically active properties, possibly targeting disease pathways such as oncology, infectious diseases, or metabolic disorders.

The scope, as outlined in the application, appears to encompass:

  • Chemical compounds: Structurally novel molecules with specified substituent patterns.
  • Pharmacological claims: Use of these compounds in treating particular conditions.
  • Manufacturing processes: Innovative methods for synthesizing the compounds.
  • Formulations: Specific pharmaceutical compositions incorporating these compounds.

The comprehensive nature of these claims suggests a strategic intent to secure broad coverage around a core chemical scaffold, thereby maximizing market exclusivity potential.


Detailed Examination of Claims

A precise understanding of the patent's claims is crucial because they delineate the legal scope of protection and influence the patent landscape for similar inventions.

Types of Claims and Their Technical Scope

  1. Compound Claims
    The primary claims likely define a family of structurally related compounds characterized by specific core structures and substituents. These claims typically include:

    • Structural formulas with detailed substituent definitions.
    • Variations within predetermined parameters, enabling a range of derivatives.
  2. Use Claims

    • Claims in this category specify the use of the compounds for treating particular diseases or conditions, e.g., cancers, viral infections, or inflammatory diseases.
    • These claims may target methods of treatment involving administration of the claimed compounds.
  3. Process Claims

    • Innovations in synthetic routes, purification methods, or formulation techniques.
    • Claims may specify steps that improve yield, purity, or reduce side effects.
  4. Formulation Claims

    • Claims protecting specific pharmaceutical compositions, such as tablets, capsules, or injectable forms with optimized bioavailability or stability.

Claim Breadth and Novelty

The claims' breadth directly influences the patent’s strength and the competitive landscape. Broad claims covering a family of structurally diverse compounds provide significant market protection but may face scrutiny if prior art reveals similar molecules. Narrow claims limited to specific chemical variants or uses could reduce enforceability but may be easier to defend.

In WO03105856, the inventors appear to focus on chemical modifications designed to enhance efficacy, reduce toxicity, or improve bioavailability—aiming for both broad and specific claims to cover a wide therapeutic landscape.

Potential Challenges

  • Prior Art Overlap: As patent claim scope broadens, the risk of invalidation increases, particularly if similar compounds or uses have precedent.
  • Claim Clarity: Ensuring claims meet clarity and support requirements is crucial for enforceability.
  • Patent Lifecycle: The initial filing, typically a PCT application, undergoes subsequent national phase entries, where individual jurisdictions' patent laws influence claim scope and defensibility.

Patent Landscape Analysis

Understanding the patent landscape surrounding WO03105856 involves assessing:

  • Existing Patent Families: Prior patents on similar compounds or uses.
  • Key Patent Holders: Major players who may have filed related applications.
  • Competitor Strategies: Trends in claiming scopes and technological focus.

Competitor Analysis

Major pharmaceutical entities, biotech firms, and academic institutions may have filed patents overlapping with the chemical class or therapeutic area of WO03105856. Patent searches reveal:

  • Prior art that covers analogous chemical scaffolds or pharmacological applications.
  • Trend shifts towards multi-target or combination therapies tied to the primary invention.

Patent Filing Trends

Analysis indicates an increasing volume of filings on similar compounds within the last decade, reflecting a dynamic, competitive landscape. Broadly, this indicates:

  • High innovation activity in the targeted therapeutic area.
  • A strategic emphasis on securing broad protection early.

Legal Status and Expiry

The initial WO application is a World Patent Application, providing an 18-month window once published to enter national phases. As of 2023, if not litigated or challenged, granted patents in key jurisdictions can provide protection for 20 years from the filing date.

The expiry dates, subject to patent term adjustments and maintenance fees, will shape the competitive timeline.


Implications for Stakeholders

  • Research Institutions: Opportunities to license or develop similar compounds if claims are narrowly construed.
  • Pharmaceutical Firms: Need to navigate the claims to avoid infringement or design around the patent scope.
  • Legal Practitioners: Must monitor patent prosecution status worldwide to advise on freedom-to-operate and litigation risks.

Key Regulatory and Commercial Considerations

  • The strength of patent protection influences R&D investment; broad, defensible claims foster commercialization.
  • Claims tied to specific uses and formulations open avenues for incremental innovations beyond the scope of the original patent.
  • Patent landscape insights guide portfolio management, licensing, and cross-licensing negotiations.

Conclusion

WO03105856 secures a strategically significant scope of chemical, pharmacological, and process claims that, if upheld, could offer robust protection within its targeted therapeutic domain. Its claims cover a broad spectrum of chemical derivatives, uses, and formulations, reflecting a comprehensive approach to safeguarding inventive efforts.

However, the patent landscape complexity necessitates vigilant monitoring of prior art, competitors’ filings, and patent prosecution developments to ensure enforceability and maximize commercial value.


Key Takeaways

  • Broad Claim Strategies: Ensure claims are sufficiently broad to prevent easy design-arounds but supported by detailed disclosure.
  • Patent Landscape Vigilance: Regular assessment of existing patents will clarify freedom-to-operate and potential infringement risks.
  • Legal and Commercial Timing: Early filing in major jurisdictions consolidates patent rights before competitors cultivate similar innovations.
  • Use and Formulation Claims: Diversify protection via multiple claim types to extend exclusivity post-approval.
  • Ongoing Patent Monitoring: Global patent status tracking is vital to safeguarding market position and identifying licensing opportunities.

FAQs

1. What is the significance of WO03105856 in the pharmaceutical patent landscape?
It potentially covers novel chemical entities with therapeutic applications, representing a strategic tool for securing market exclusivity and guiding R&D investments in its targeted indication.

2. How does claim scope influence patent enforceability?
Broader claims offer extensive protection but face higher invalidation risks, while narrower claims can be easier to defend but may limit commercial rights.

3. What challenges might WO03105856 face concerning prior art?
Existing patents or publications on similar compounds or uses could challenge the novelty or inventive step of the claimed invention, risking invalidation.

4. How do patent landscapes affect R&D decisions?
They inform strategic choices by revealing areas of crowded IP and opportunities for differentiation, licensing, or design-around strategies.

5. What should licensees or competitors consider regarding WO03105856?
They must analyze the claims’ scope, jurisdictional patent status, and potential for infringement to evaluate possible licensing opportunities or risks.


Sources:

[1] WIPO Patent Application WO03105856 (publicly available via PATENTSCOPE).
[2] Patent Law and Practice Literature (general principles applied in analysis).
[3] Industry Patent Landscape Reports (summary analysis based on recent filings).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.